Cue Biopharma Inc.

11/08/2024 | Press release | Distributed by Public on 11/08/2024 12:43

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE 101 and CUE 102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.